Warifteine therapeutic treatment reduced leukocyte recruitment and anxiety-like response in ovalbumin-induced allergic pulmonary inflammation / Tratamento terapêutico com warifteína reduz recrutamento de leucócitos e resposta semelhante á ansiedade na inflamação pulmonar alérgica induzida por ovalbumina

Hianka Greice Lopes de Sousa, Laércia Karla Diega Paiva Ferreira, Humberto de Carvalho Aragão Neto, Atalia Ferreira de Lima Flôr, José Maria Barbosa- Filho, José Luiz de Brito Alves, Valdir de Andrade Braga, Reinaldo Nóbrega de Almeida, Marcia Regina Piuvezam, Cláudio Roberto Bezerra dos Santos


Pulmonary inflammation plays a fundamental role in the pathophysiology of allergic asthma, which is characterized by lower airway obstruction, bronchial hyperresponsiveness, tissue remodeling, recruitment of inflammatory cells, with a predominance of eosinophils, in addition to behavioral disorders such as anxiety. The aim of this study was to evaluate the therapeutic effect of the alkaloid warifteine, from the medicinal plant Cissampelos sympodialis, on anxiety-like behavior, respiratory frequency and leukocyte recruitment in an experimental model of allergic pulmonary inflammation. Swiss female mice were sensitized and challenged with ovalbumin (OVA) throughout the experimental protocol. The animals were treated orally with warifteine (2 mg / kg), subcutaneously with dexamethasone (2 mg / kg) or intraperitoneally with diazepam (1 mg / kg), 1 h after the OVA-challenges. On the last day of the antigenic challenge, the mice were tested for behavior using the Elevated Plus Maze (EPM) and for respiratory rate using full body plethysmography. The following day, the mice were euthanized to collect the bronchoalveolar lavage fluid (BALF) and leukocyte count. The data obtained showed that OVA-sensitization induced a behavior similar to anxiety in mice since the EPM test showed that the OVA group increased the number of entries and the time spent in the closed arms (CA) of the apparatus and reduced these parameters in the open arms (OA) compared to the Salina group. Warifteine treatment reversed both parameters analyzed, increasing the time spent (p <0.0001) and number of entries (p <0.01) in OA, decreasing the time spent (p <0.01) and number of entries (p <0.0001) in the CA, similarly to dexamethasone and diazepam standard drugs. Warifteine also reduced the respiratory rate (p <0.01) compared to the OVA group. The behavioral and breathing changes of the tested animals showed a relationship with the increase in the total and differential inflammatory leukocyte number in the OVA group compared to the Saline group. Therapeutic treatment with warifteine decreased the inflammatory process, reducing the number of total cells (p <0.0001) dependent of eosinophils and neutrophils numbers (p <0.001), as well as the percentage of eosinophils (p <0.0001). These data show that therapeutic treatment with warifteine is able to inhibit anxiety-like behavior and respiratory rate, due to a mechanism related to the inhibition of eosinophilic migration in an experimental model of allergic pulmonary inflammation.


Alkaloid, Airway disease, Psychological disorder.

Full Text:



Stern J, Pier J, Litonjua AA. Asthma epidemiology and risk factors. Seminars in Immunopathology, v.42, p.5-15, 2020. https://doi.org/10.1007/s00281-020-00785-1.

Athari, SS. Targeting cell signaling in allergic asthma. Signal Transduction and Targeted Therapy, v.4, p.1-19, 2019. https://doi.org/10.1038/s41392-019-0079-0.

Gandhi GR, Vasconcelos ABS, Haran GH, Calisto VKS, Jothi G, Quintans JSS, Cuevas LE, Narain N, Junior LJQ, Cipolotti R, Gurgel RQ. Essential oils and its bioactive compounds modulating cytokines: A systematic review on anti-asthmatic and immunomodulatory properties. Phytomedicine, v.73, p.1-9, 2019.


Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. https://ginasthma.org/

Bedolla-Oarajas M, Morales-Romero J, Fonseca-López JC, Pulido-Guillén NA, Larenas-Linnemann D, Hernández-Colín DD. Anxiety and depression in adult patients with asthma: the role of asthma control, obesity and allergic sensitization. Journal of Asthma, v. 57, p.1-12, 2020. https://doi.org/10.1080/02770903.2020.1759087.

Luria CJ, Sitarik AR, Havstad S, Zoratti EM, Kim H, Wegienka GR, Joseph CLM, Cassidy-Bushrow AE. Association between asthma symptom scores and perceived stress and trait anxiety in adolescents with asthma. Allergy and Asthma Proceedings, v.41, p.210-217, 2020. https://doi.org/10.2500/aap.2020.41.200017.

Campos AC, Fogaça MV, Aguiar DC, Guimarães FS. Animal models of anxiety disorders and stress. Revista Brasileira de Psiquiatria, v.35(2), p.S101-S111, 2013. https://doi.org/10.1590/1516-4446-2013-1139.

Palermo-Neto J, Alves GJ. Neuroimunomodulação: influências do sistema imune sobre o sistema nervoso central. Revista Neurociências, v. 18(2), p.214-219, 2010. https://doi.org/10.34024/rnc.2010.v18.8484.

Nutma E, Willison H, Gianvito M, Amor S. Neuroimmunology - The Past, Present and Future. Clinical & Experimental Immunology, v.197(3), p.278-293, 2019. https://doi.org/10.1111/cei.13279.

Kaoata H, Artis D. Neuro-immune crosstalk and allergic inflammation. The Journal of Clinical Investigation, v.129(4), p.1475-1482, 2019.


Theoharides TC. The Impact of Psychological Stress on Mast Cells. Annals of Allergy, Asthma & Immunology, S1081-1206, 2020.


Stanescu S, Kirby SE, Thomas M, Yardley L, Ainsworth B. A systematic review of psychological, physical health factors, and quality of life in adult asthma. Primary Care Respiratory Medicine, v.29, p.1-11, 2019. https://doi.org/10.1038/s41533-019-0149-3.

Kato A, Takahashi K, Homma I. Relationships between trait and respiratory parameters during quiet breathing in normal subjects. The Journal of Physiological Sciences, v.68, p.369-376, 2017. https://doi.org/10.1007/s12576-017-0539-7.

Bondarenko E, Hodgson DM, Nalivaiko E. Amygdala mediates respiratory responses to sudden arousing stimuli and to restraint stress in rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, v.306(12), p.951–959, 2014. https://doi.org/10.1152/ajpregu.00528.2013.

Hegoburu C, Shionoya K, Garcia S, Messaoudi B, Thévenet M, Mouly A-M. The RUB Cage: Respiration–Ultrasonic Vocalizations–Behavior Acquisition Setup for Assessing Emotional Memory in Rats. Frontiers in Behavioral Neuroscience, v.5, p.1-13, 2011. https://doi.org/10.3389/fnbeh.2011.00025.

Edgell H, Moore LE, Chung C, Byers BW, Stickland MK. Short-term cardiovascular and autonomic effects of inhaled salbutamol. Respiratory Physiology Neurobiology, v.231, p.14-20, 2016. https://doi.org/10.1016/j.resp.2016.05.014.

Heffler E, Madeira LNG, Ferrando M, Puggioni F, Racca F, Malvezzi L, Passalacqua G, Canonica GW. Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma. The Journal of Allergy and Clinical Immunology: In Practice, v.6(3), p.776-781, 2018. https://doi.org/10.1016/j.jaip.2018.01.025.

Harada H, Kashiwadani H, Kanmura Y, Kuwaki T. Linalool Odor-Induced Anxiolytic Effects in Mice. Frontiers in Behavioral Neuroscience, v.12, p.1-8, 2018. https://doi.org/10.3389/fnbeh.2018.00241.

Barbosa-Filho JM, Agra MF, Thomas G. Botanical, chemical and pharmacological investigation on Cissampelos species from Paraíba (Brazil). Journal of the Brazilian Association for the Advancement of Science, v.49, p.386-394, 1997.

De Melo ICAR, De Souza ILL, Vasconcelos LHC, Scotti MT, Da Silva BA, Schripsemab J, Aventino HF, Oliveira EJ. Metabolomic fingerprinting of Cissampelos sympodialis Eichler leaf extract and correlation with its spasmolytic activity. Journal of Ethnopharmacology, v. 253, p.1-9, 2020. https://doi.org/10.1016/j.jep.2020.112678.

Melo PS, Cavalcante HMM, Barbosa-Filho JM, Diniz MFFM, Medeiros IA, Haun M. Warifteine and milonine, alkaloids isolated from Cissampelos sympodialis Eichl: cytotoxicity on rat hepatocyte culture and in V79 cells. Toxicology Letters, v.142(1-2), p.143–151, 2003. https://doi.org/10.1016/S0378-4274(03)00064-X.

De Sales IRP, Formiga RDO, Machado FDF, Nascimento RF, Pessoa MMB, Barros MEFX, Vieira GC, Gadelha FAAF, Marinho AF, Barbosa-Filho JM, Júnior RFA, Antunes AA, Batista LM. Cytoprotective, antioxidant and anti-inflammatory mechanism related to antiulcer activity of Cissampelos sympodialis Eichl. in animal models. Journal of Ethnopharmacology, v.222, p.190-200, 2018. https://doi.org/10.1016/j.jep.2018.04.019.

Bezerra-Santos CR, Vieira-De-Abreu A, Barbosa-Filho JM, Oandeira-Melo C, Piuvezam MR, Bozza PT. Anti-allergic properties of Cissampelos sympodialis and its isolated alkaloid warifteinee. International Immunopharmacology, v.6, p.1152-1160, 2006. https://doi.org/10.1016/j.intimp.2006.02.007.

Bezerra-Santos CR, Vieira-De-Abreu A, Vieira GC, Ribeiro-Filho J, Barbosa-Filho JM, Pires AL, Martins MA, Souza HS, Bandeira-Melo C, Bozza PT, Piuvezam MR. Effectiveness of Cissampelos sympodialis and its isolated alkaloid warifteinee in airway hyperreactivity and lung remodeling in a mouse model of asthma. International Immunopharmacology, v. 13, p. 148-155, 2012.


Vieira GC, Lima JF, Figueiredo RCBQ, Mascarenhas SR, Bezerra-Santos CR, Piuvezam MR. Inhaled Cissampelos sympodialis down-regulates airway allergic reaction by reducing lung CD3+T cells. Phytotherapy Research, v.27, p.916-925, 2013. https://doi.org/10.1002/ptr.4791.

Vieira GC, Gadelha FAAF, Pereira RF, Ferreira LKDP, Barbosa-Filho JM, Bozza PT, Piuvezam MR. Warifteine, an alkaloid of Cissampelos sympodialis, modulates allergic profile in a chronic allergic rhinitis model. Revista Brasileira de Farmacognosia, v.28(1), p.50-56, 2017. https://doi.org/10.1016/j.bjp.2017.10.009.

Lima TFA, Rocha JDB, Guimarães-Costa AB, Barbosa-Filho JM, Decoté-Ricardo D, Saraiva EM, Arruda LB, Piuvezam MR, Peçanha LMT. Warifteine, an Alkaloid Purified from Cissampelos sympodialis, Inhibits Neutrophil Migration In Vitro and In Vivo. Journal of Immunology Research, v.2014, p.1-12, 2014. https://doi.org/10.1155/2014/752923.

Costa HF, Bezerra-Santos CR, Barbosa-Filho JM, Martins MA, Piuvezam MR. Warifteine, a bisbenzylisoquinoline alkaloid, decreases immediate allergic and thermal hyperalgesic reactions in sensitized animals. International Immunopharmacology, v.8(4), p.519-525, 2008. https://doi.org/10.1016/j.intimp.2007.11.009.

Rocha JDB, Decoté-Ricardo D, Redner P, Lopes UG, Barbosa-Filho JM, Piuvezam MR, Arruda LB, Peçanha LMT. Inhibitory effect of the alkaloid warifteine purified from Cissampelos sympodialis on B lymphocyte function in vitro and in vivo. Planta Medica, v.76(4), p.325-330, 2010. DOI:10.1055/s-0029-1186165.

Almeida RN, Navarro DS, Assis TS, Medeiros IA. Antidepressant effect of an ethanolic extract of leaves of Cissampelos sympodialis in rats and mice. Journal of Ethnopharmacology, v.63(3), p.247-252, 1998. https://doi.org/10.1016/S0378-8741(98)00086-5.

Mendonça-Netto S. Varela RWB, Fechine MF, Queiroga MNG, Souto-Maior FN, Almeida RN. Antidepressant effects of total tertiary alkaloid fraction of Cissampelos sympodialis Eichler in rodents. Revista Brasileira de Farmacognosia, v.18(2), p.165-169, 2008. https://doi.org/10.1590/S0102-695X2008000200004.

Lloyd CM, Gonzalo JA, Nguyen T, Delaney T, Tian J, Oettgen H, Coyle AJ, Gutierrez-Ramos JC. Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. The Journal of Immunology, v.166(3), p.2033-2040, 2001.


Oartlett DJ, Tenney SM. Control of breathing in experimental anemia. Respiration Physiology, v.10(3), p.384-95, 1970. https://doi.org/10.1016/0034-5687(70)90056-3.

Mozzini-Monteiro T, Costa HF, Vieira GC, Salgado PRR, Salvadori MGSS, Almeida RN, Souza MFV, Matias WN, Braga VA, Nalivaiko E, Piuvezam MR. Anti-asthmatic and anxiolytic effects of Herissantia tiubae, a Brazilian medicinal plant. Immunity, Inflammation and Disease, v.4(2), p.201-212, 2016. https://doi.org/10.1002/iid3.107.

Bezerra-Santos CR, Bondarenko E, Essilfie AT, Nair PM, Horvat JC, Barbosa-Filho JM, Piuvezam MR, Nalivaiko E, Hansbro PM. Cissampelos sympodialis and Warifteine Suppress Anxiety-Like Symptoms and Allergic Airway Inflammation in Acute Murine Asthma Model. Revista Brasileira de Farmacognosia, v.30, p.224–232, 2020. https://doi.org/10.1007/s43450-020-00026-4.

Hakimeh D, Tripodi S. Recent advances on diagnosis and management of childhood asthma and food allergies. Italian Journal of Pediatrics, v.39, p.80-89, 2013. https://doi.org/10.1186/1824-7288-39-80.

Oland AA, Booster GD, Bender BG. Psychological and lifestyle risk factors for asthma exacerbations and morbidity in children. World Allergy Organization Journal, v.10, p.1-7, 2017. https://doi.org/10.1186/s40413-017-0169-9.

Andrade HHN, Monteiro AB, Braga RM, Cruz RMD, Salvadori MGSS, Scotti MT, Sousa DP, Almeida RN. Anxiolytic and antinociceptive-like effects of cinnamic alcohol by possible GABAergic pathway modulation: In vivo and in silico studies. Brazilian Journal of Development, v 6, p. 51372-51389. DOI:10.34117/ bjdv6n7-690.

Lanza FC, Corso SD. Fisioterapia no paciente com asma: intervenção baseada em evidências. Arquivos de Asma, Alergia e Imunologia, v.1(1), p.59-64, 2017. DOI: 10.5935/2526-5393.20170008.

Gualdi LP, Pereira AC, Masiero L, Nuñez NK, Cao R, Pitrez PMC. Modelos murinos para pesquisas em asma. Scientia Medica, v. 20(3), p. 236-242, 2010.

Weller PF. Human eosinophils. Journal of Allergy and Clinical Immunology, v.100(3), p.283-287, 1997. https://doi.org/10.1016/S0091-6749(97)70237-9.

Humbles AA. A Critical Role for Eosinophils in Allergic Airways Remodeling. Science, v.305(5691), p.1776-1779, 2004. DOI: 10.1126/science.1100283.

Davoine F, Lacy P. Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity. Frontiers in Immunology, v.5, p.1-17, 2014.


Ribeiro-Filho J, Leite FC, Calheiros AS, Carneiro AB, Azeredo JA, Assis EF, Dias CS, Piuvezam MR, Bozza PT. Curine Inhibits Macrophage Activation and Neutrophil Recruitment in a Mouse Model of Lipopolysaccharide-Induced Inflammation. Toxins, v.11, p. 1-12, 2019. https://doi.org/10.3390/toxins11120705.

Radermecker C, Louis R, Bureau F, Marichal T. Role of neutrophils in allergic asthma. Current Opinion in Immunology, v.54, p.28-34, 2018.


Vieira GC, De Lima JF, De Figueiredo RC, Mascarenhas SR, Bezerra-Santos CR, Piuvezam MR. Inhaled Cissampelos sympodialis down-regulates airway allergic reaction by reducing lung CD3+ T cells. Phytotherapy Research, v.27, 916-925, 2013. https://doi.org/10.1002/ptr.4791.

DOI: https://doi.org/10.34117/bjdv6n9-124


  • There are currently no refbacks.